[Use of dimetpramid for the prevention and treatment of neurotoxic reactions during radio- and chemotherapy of lymphogranulomatosis].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000932:Antiemetics / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides / Q000008:administration & dosage*; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D007273:Injections, Intramuscular; D008875:Middle Aged; D009325:Nausea / Q000188:drug therapy / Q000209:etiology; D011878:Radiotherapy / Q000009:adverse effects*; D014839:Vomiting / Q000188:drug therapy / Q000209:etiology
D000932:Antiemetics; D000970:Antineoplastic Agents; D001549:Benzamides; C037141:dimetpramid
Primenenie dimetpramida dlia profilaktiki i lecheniia neĭrotoksicheskikh reaktsiĭ pri luchevoĭ i khimioterapii bol'nykh limfogranulematozom.